Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening.
about
Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human HealthPost-transcriptional regulation in metabolic diseasesmicroRNA in the development of diabetic complications.MicroRNAs in adipogenesis and as therapeutic targets for obesity.Small molecules targeting hepatitis C virus-encoded NS5A cause subcellular redistribution of their target: insights into compound modes of action.Circulating microRNAs in patients with non-alcoholic fatty liver diseaseIncreasing the Content of High-Content Screening: An OverviewDifferential phosphorylation of perilipin 1A at the initiation of lipolysis revealed by novel monoclonal antibodies and high content analysisMicroRNAs and liver disease.MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.Quantification of hormone sensitive lipase phosphorylation and colocalization with lipid droplets in murine 3T3L1 and human subcutaneous adipocytes via automated digital microscopy and high-content analysis.Epigenetic regulation in alcoholic liver disease.The effect of miRNA-122 in regulating fat deposition in a cell line model.MicroRNAs in β-cell biology, insulin resistance, diabetes and its complicationsMicro RNAs in the development of non-alcoholic fatty liver disease.A Potential of microRNAs for High-Content ScreeningMicroRNA Screening and the Quest for Biologically Relevant Targets.Genetic and epigenetic variants influencing the development of nonalcoholic fatty liver disease.Novel hepatic microRNAs upregulated in human nonalcoholic fatty liver diseaseComplexity of microRNA function and the role of isomiRs in lipid homeostasis.Structure, function and metabolism of hepatic and adipose tissue lipid droplets: implications in alcoholic liver disease.miR-29a Promotes Lipid Droplet and Triglyceride Formation in HCV Infection by Inducing Expression of SREBP-1c and CAV1.The functional role of microRNAs in alcoholic liver injury.microRNAs: fad or future of liver disease.Expression of microRNAs: potential molecular link between obesity, diabetes and cancer.miRNAs, polyphenols, and chronic disease.Inflammation and liver tumorigenesis.Epigenetic effects of ethanol on the liver and gastrointestinal system.Progress in the search for circulating biomarkers of nonalcoholic fatty liver disease.Epigenetic harnessing of HCV via modulating the lipid droplet-protein, TIP47, in HCV cell models.miR-148a and miR-30a limit HCV-dependent suppression of the lipid droplet protein, ADRP, in HCV infected cell models.The miR-181d-regulated metalloproteinase Adamts1 enzymatically impairs adipogenesis via ECM remodeling.Posttranscriptional regulation of lipid metabolism by non-coding RNAs and RNA binding proteins.Maternal high-fat diet consumption modulates hepatic lipid metabolism and microRNA-122 (miR-122) and microRNA-370 (miR-370) expression in offspring.MicroRNA and Adipogenesis.
P2860
Q26765463-72989A5F-8D66-4CF1-8752-ADC212D130ECQ27028039-F332B1CF-830B-4EF4-B005-CA526882CF9FQ30353835-E82098BD-4667-4B2B-8488-8E6636D3AADCQ30400205-DFF822AC-0971-430B-A033-6ED7DACA60CCQ33878202-A2521CDD-DF2A-4826-B7B3-00E43C3617E2Q34179239-1AA9CF0E-A27D-4521-A336-6974D9A27389Q34505840-FAFD8745-E761-493B-A7D1-FDA8C97178D1Q34584283-026ABB04-E695-45C3-B834-5D0999BD8785Q34717904-2D26E69C-3B6F-4EF5-8553-D70B76527093Q34750679-6B649534-DCCE-4521-9747-D14B2FF39028Q35007906-4D5C4D50-AF60-40CC-96C9-0463D0BE4121Q35012703-8187A34C-071D-49C8-9972-C2997AB87928Q35056293-24BD6018-9385-4164-8DB8-EF7DA120635AQ35063263-1021C47B-295A-49B5-A485-80684FCE3E87Q35127045-71953A32-C16C-4133-AA15-FA3F66237ABEQ35212807-99BCA709-B91C-4DA1-B328-A5B4E245A5BCQ35590504-F7B570F8-D029-4984-B4C8-7BE87CC1C9C2Q36450465-7C30738D-30F6-473E-9909-C3C123C514CEQ36597717-00D60A2D-8B92-4000-8A06-6BF53D336439Q36754775-E92CF972-AD7E-4813-BEA3-33C98560D426Q36764000-1E919559-0A9D-436B-9746-6B4722EE45D0Q37578279-07F4B3AA-7F07-4139-A495-E728C0AB04AFQ37595286-B313FCEC-47EA-41C2-8006-35569639DFF0Q37883932-519FF2D3-0CAA-4976-A6CD-1F863B90E727Q37902256-DC790C2B-8516-48AF-A292-D169EF315C58Q38061096-3E2C5EF5-4B58-45BF-890F-6B461B8C7744Q38107461-4F528F6A-7667-41DD-B995-4E3596CF57E0Q38169189-040B19C2-3B17-4B7E-B375-E8A004136581Q38246145-C13A811E-706A-43B4-92CC-E53F91D4406BQ38853505-A0B03BC6-BCEF-43BF-9EB5-362717344394Q40552844-14902043-D888-4755-BBF2-A85A5A16B667Q42709950-CC44170E-C606-477D-A53D-787025E309F3Q46252515-A81AE686-2108-4CB3-B439-0B5FDDFA4A63Q50675151-7815E0BF-81F4-4C43-9068-C852FE5C9D22Q50957766-06DAF299-75BD-444C-A96E-B605B0766827
P2860
Identification of MicroRNAs that control lipid droplet formation and growth in hepatocytes via high-content screening.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Identification of MicroRNAs th ...... es via high-content screening.
@ast
Identification of MicroRNAs th ...... es via high-content screening.
@en
type
label
Identification of MicroRNAs th ...... es via high-content screening.
@ast
Identification of MicroRNAs th ...... es via high-content screening.
@en
prefLabel
Identification of MicroRNAs th ...... es via high-content screening.
@ast
Identification of MicroRNAs th ...... es via high-content screening.
@en
P2093
P2860
P356
P1476
Identification of MicroRNAs th ...... es via high-content screening.
@en
P2093
Eigo Suyama
Eugene Sisman
Jeffrey H Price
Patricia A Loy
Patrick M McDonough
Pedro Aza-Blanc
Randall S Ingermanson
Ross Whittaker
P2860
P304
P356
10.1177/1087057110374991
P577
2010-07-16T00:00:00Z